Related Experiment Video
Updated: Mar 13, 2026

09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.6K
Report on noninvasive prenatal testing: classical and alternative approaches.
Kateryna S Pantiukh1, Nikolay N Chekanov2, Igor V Zaigrin2
1Genoanalytica, CJSC, Moscow, Russian Federation; Faculty of Biology, Moscow State University, Moscow, Russian Federation.
F1000Research
|October 27, 2016
Summary
Noninvasive prenatal testing (NIPT) using massive parallel sequencing shows promise. An allelic difference method for determining fetal DNA fraction is effective for both sexes and warrants further large-scale trials.
Area of Science:
- Genetics
- Prenatal Diagnostics
- Bioinformatics
Background:
- Traditional prenatal aneuploidy testing methods have limitations including accuracy and safety concerns.
- Noninvasive prenatal testing (NIPT) based on genetics has emerged as a superior alternative.
- NIPT has been rapidly adopted globally following successful clinical trials.
Purpose of the Study:
- To evaluate the efficacy of NIPT methods in a Moscow, Russia cohort.
- To assess alternative approaches for NIPT, focusing on fetal DNA fraction determination.
- To validate novel methods for improved NIPT reliability.
Main Methods:
- Massive parallel sequencing was used to analyze 1012 samples for chromosome coverage.
- Two NIPT approaches were investigated: maternal/fetal differential methylation and allelic difference.
- Chromosome Y representation was measured using real-time PCR and whole-genome sequencing.
Main Results:
- The maternal/fetal differential methylation approach yielded unstable results.
- The allelic difference method proved promising for NIPT.
- Chromosome Y representation measures by PCR and sequencing were highly correlated (r=0.94).
- A novel maternal/fetal allelic difference method showed good correlation with chromosome Y estimates (r=0.74).
Conclusions:
- The allelic difference method is a promising approach for NIPT, applicable to both sexes.
- Accurate determination of fetal cell-free DNA fraction is crucial for reliable NIPT results.
- Further large-scale trials are recommended for the novel allelic difference-based NIPT method.

